Addus HomeCare (NASDAQ:ADUS) Releases Quarterly Earnings Results, Beats Expectations By $0.24 EPS

Addus HomeCare (NASDAQ:ADUS) issued its earnings results on Monday. The company reported $1.21 EPS for the quarter, beating analysts’ consensus estimates of $0.97 by $0.24, Briefing.com reports. Addus HomeCare had a return on equity of 9.70% and a net margin of 5.91%. The business had revenue of $280.70 million during the quarter, compared to analyst estimates of $279.49 million. During the same period in the prior year, the company posted $0.84 earnings per share. Addus HomeCare’s revenue was up 11.6% on a year-over-year basis.

Addus HomeCare Trading Up 1.8 %

NASDAQ:ADUS traded up $1.84 on Wednesday, reaching $106.43. The company’s stock had a trading volume of 7,342 shares, compared to its average volume of 123,152. Addus HomeCare has a 1-year low of $78.35 and a 1-year high of $106.43. The business’s 50-day moving average price is $98.73 and its two-hundred day moving average price is $92.61. The firm has a market cap of $1.74 billion, a PE ratio of 27.24, a PEG ratio of 1.94 and a beta of 0.96. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.38 and a current ratio of 1.38.

Wall Street Analyst Weigh In

A number of research firms have recently commented on ADUS. Bank of America raised their price objective on shares of Addus HomeCare from $115.00 to $118.00 and gave the stock a “buy” rating in a report on Tuesday. Barclays cut Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 target price for the company. in a report on Tuesday, April 23rd. William Blair reiterated an “outperform” rating on shares of Addus HomeCare in a research note on Monday, February 5th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $102.00 target price on shares of Addus HomeCare in a report on Thursday, February 29th. Finally, Oppenheimer restated an “outperform” rating and issued a $118.00 price target on shares of Addus HomeCare in a research report on Tuesday, March 26th. One equities research analyst has rated the stock with a sell rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $106.57.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.